Natural Health Products Ingredients Database
WHAT'S NEW
What's New is a listing of modifications to the NHPID since the last update. This page was most recently revised on June 28, 2024.
- Announcements
- New Ingredients
- Removed Ingredients
- Revised NHPID Names
- Revised Proper and Common Names
- New Roles
- Revised Restrictions
- Other Ingredient Modifications
- Monograph Modifications
- AbLS Modifications
- Controlled Vocabulary Modifications
- Homeopathic Ingredient Modifications
- Previous What's New
ANNOUNCEMENTS
The updates to the NHPID listed below apply to the most recent version of the web-based Product Licence Application (web PLA) form. All new product licence application submissions must use the web PLA form.
New Ingredients
In this update, the following non-homeopathic ingredients were added.
NHPID Name:
Glyceryl Citrate/Lactate/Linoleate/Oleate
Role:
Non-medicinal
NHPID Name:
Isospaglumic Acid
Role:
Medicinal
NHPID Name:
Sodium Spaglumate
Role:
No Role
NHPID Name:
Magnesium Citrate Glycinate
Role:
No Role
NHPID Name:
Acetamidoethoxyethanol
Role:
Non-medicinal
NHPID Name:
Dipicolinic Acid
Role:
Non-medicinal
NHPID Name:
Piper Nigrum (Pepper) Seed Extract
Role:
Non-medicinal
NHPID Name:
Epimedium Sagittatum Leaf/Stem Extract
Role:
Non-medicinal
NHPID Name:
Nicotine Malate
Role:
No Role
Removed Ingredients
In this update, the following non-homeopathic ingredients were removed.
No Changes.
Revised NHPID Names
In this update, the following non-homeopathic ingredients had their NHPID name revised.
Old NHPID Name:
Citrus Nobilis Peel Oil
New NHPID Name:
Citrus Nobilis (Mandarin Orange) Peel Oil
Old NHPID Name:
Hydroxyethoxyphenyl butanone
New NHPID Name:
Hydroxyethoxyphenyl Butanone
Old NHPID Name:
Hydrolyzed beef protein
New NHPID Name:
Hydrolyzed Beef Protein
Revised Proper and Common Names
In this update, the following non-homeopathic ingredients had their common or proper names revised.
NHPID Name:
Diisopropylamine
Removed Proper Name(s):
Diisopropylamine
NHPID Name:
Diisopropylamine
New Proper Name(s):
N-(1-Methylethyl)-2-propanamine
NHPID Name:
Citric acid
Removed Common Name(s):
Anhydrous citric acid
NHPID Name:
Sodium citrate dihydrate
Removed Proper Name(s):
Trisodium citrate dihydrate
NHPID Name:
Sodium Glycolate
Removed Proper Name(s):
Sodium Glycolate
NHPID Name:
Sodium Glycolate
New Proper Name(s):
Acetic acid, 2-hydroxy-, sodium salt (1:1)
NHPID Name:
Zinc malate
Removed Common Name(s):
2-hydroxybutanedioate; zinc(+2) cation; Malic acid, zinc salt
NHPID Name:
Zinc malate
Removed Proper Name(s):
Zinc malate
NHPID Name:
Zinc malate
New Common Name(s):
Zinc malate
NHPID Name:
Zinc malate
New Proper Name(s):
Butanedioic acid, hydroxy-, zinc salt (1:1)
NHPID Name:
Citrus Nobilis (Mandarin Orange) Peel Oil
Removed Common Name(s):
Citrus Nobilis (Mandarin Orange) Peel Essential Oil; Citrus Nobilis Peel Essential Oil
NHPID Name:
Citrus Nobilis (Mandarin Orange) Peel Oil
New Common Name(s):
Citrus nobilis (Mandarin orange) peel oil; Citrus nobilis peel oil
NHPID Name:
Hydrolyzed Beef Protein
Removed Common Name(s):
Hydrolyzed beef protein
NHPID Name:
Hydrolyzed Beef Protein
Removed Proper Name(s):
Hydrolyzed beef protein
NHPID Name:
Hydrolyzed Beef Protein
New Common Name(s):
Hydrolyzed beef protein
NHPID Name:
Hydrolyzed Beef Protein
New Proper Name(s):
Hydrolyzed beef protein
NHPID Name:
Apocynum venetum
New Common Name(s):
Dogbane
NHPID Name:
Hexamidine diisethionate
Removed Proper Name(s):
2-Hydroxyethanesulphonic acid, compound with 4,4'-(hexane-1,6-diylbis(oxy))bis(benzenecarboxamidine) (2:1)
NHPID Name:
Hexamidine diisethionate
New Proper Name(s):
2-Hydroxyethanesulphonic acid, compound with 4,4'-(hexane-1,6-diylbis(oxy))bis(benzenecarboxamidine) (2:1)
NHPID Name:
Hydroxyethoxyphenyl Butanone
Removed Proper Name(s):
Hydroxyethoxyphenyl butanone
NHPID Name:
Hydroxyethoxyphenyl Butanone
New Proper Name(s):
4-(3-Ethoxy-4-hydroxyphenyl)-2-butanone
New Roles
In this update, the roles of the following non-homeopathic ingredients were changed.
NHPID Name:
Creatine hydrochloride
Old Role:
Medicinal
New Role:
No role
NHPID Name:
Diisopropanolamine
Old Role:
Non-medicinal
New Role:
No role
NHPID Name:
DEA-Cetyl phosphate
Old Role:
Non-medicinal
New Role:
No role
NHPID Name:
DEA-Oleth-3 Phosphate
Old Role:
Non-medicinal
New Role:
No role
NHPID Name:
Diisopropylamine
Old Role:
Non-medicinal
New Role:
No role
NHPID Name:
Sodium citrate dihydrate
Old Role:
Medicinal & Non-medicinal
New Role:
Non-medicinal
NHPID Name:
Tricreatine citrate
Old Role:
Medicinal
New Role:
No role
NHPID Name:
D-Psicose
Old Role:
Non-medicinal
New Role:
Medicinal & Non-medicinal
Revised Restrictions
In this update, the following non-homeopathic ingredients underwent a modification related to their restrictions.
NHPID Name:
Chlorocresol
Non-medicinal Restriction(s) changed:
For topical use only, up to 0.1%, in products associated with the following risk statement: "Do not use in the area of the eye, mouth or nose". Not permitted in products intended to be used on or around mucosal membranes such as eyes, nose or mouth.
NHPID Name:
D&C Violet No. 2
Non-medicinal Restriction(s) changed:
For external use only, up to 0.3% other than in nail products.
NHPID Name:
Citric acid
Non-medicinal Restriction(s) changed:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
Citric acid monohydrate
Non-medicinal Restriction(s) changed:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
Potassium citrate
New Non-medicinal Restriction(s) added:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
Potassium citrate, monohydrate
New Non-medicinal Restriction(s) added:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
Sodium citrate
New Non-medicinal Restriction(s) added:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
Sodium citrate dihydrate
New Non-medicinal Restriction(s) added:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
Glycolic acid
Non-medicinal Restriction(s) changed:
For topical use only. For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
Sodium Glycolate
New Non-medicinal Restriction(s) added:
For topical use only. For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
D-Lactic acid
Non-medicinal Restriction(s) changed:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
DL-Lactic acid
Non-medicinal Restriction(s) changed:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
L-Lactic acid
Non-medicinal Restriction(s) changed:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
D-Malic acid
Non-medicinal Restriction(s) changed:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
DL-Malic acid
Non-medicinal Restriction(s) changed:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
L-Malic acid
Non-medicinal Restriction(s) changed:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
Sodium hydrogen DL-malate
Non-medicinal Restriction(s) changed:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
dl-Mandelic acid
Non-medicinal Restriction(s) changed:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
DL-Tartaric acid
Non-medicinal Restriction(s) changed:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
L-Tartaric acid
Non-medicinal Restriction(s) changed:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
Gluconolactone
Non-medicinal Restriction(s) changed:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
Lactobionic acid
Non-medicinal Restriction(s) changed:
For skin products, the concentration of alpha-hydroxy acids alone or in combination (including polyhydroxy acids and bionic acids with alpha hydroxyl groups, and their salts), when used as non-medicinal ingredients, should be lower than 3% and not contribute to the product's pharmacological effects.
NHPID Name:
Hydroquinone
New Medicinal Restriction(s) added :
Up to 2% in preparations for topical use on the skin.
NHPID Name:
Citrus Nobilis (Mandarin Orange) Peel Oil
New Non-medicinal Restriction(s) added:
Detail: For topical use only, up to 0.1%, when formulated to be non-sensitizing and non-irritating, and provided that leave-on products do not contain more than 15 ppm 5-methoxypsoralen.
NHPID Name:
Bos taurus
Medicinal Restriction(s) Changed :
Detail: In the product licence application form, the preparation can be selected from all organism part preparation types applicable to non-human animal materials that are in the Controlled Vocabulary of the Natural Health Products Ingredients Database.
NHPID Name:
Sus scrofa
Medicinal Restriction(s) Changed :
Detail: In a product licence application, the preparation can be selected from all organism part preparation types applicable to non-human animal material that are in the Controlled Vocabulary of the Natural Health Products Ingredients Database.
NHPID Name:
Apocynum venetum
Medicinal Restriction(s) Changed :
Detail: Apocynum venetum leaves contain cardiac glycosides. Therefore, the NNHPD requires that products containing Apocynum venetum leaves include the risk statement "Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you have a cardiovascular disease" on the product licence application form and label before an NPN will be granted.
NHPID Name:
Hexamidine diisethionate
Non-medicinal Restriction(s) changed:
General
NHPID Name:
Hydroxyethoxyphenyl Butanone
Non-medicinal Restriction(s) changed:
General
NHPID Name:
D-Psicose
New Route(s) of Adminstration added:
Oral
NHPID Name:
D-Psicose
New Non-medicinal Restriction(s) added:
Detail: For oral use only.
Other Ingredient Modifications
In this update, the following non-homeopathic ingredients underwent a modification different from those listed above, such as new source material, new preparation type, or new sub-ingredient relationship, etc.
NHPID Name:
Creatine
New Source Ingredient(s) added:
Polyethylene glycosylated creatine; Polyethylene glycosylated creatine hydrochloride
NHPID Name:
Creatine
Additional Details changed:
The finished product and/or raw material specifications must meet the process-related impurity acceptance criteria outlined in the USP Creatine monograph (or any other internationally recognized pharmacopoeia). Note that the NNHPD will accept these process-related impurity acceptance criteria for either the finished product or the raw material; however, the procedures described in the USP Creatine monograph are specific to the testing of creatine monohydrate raw material. As per the NNHPD Quality of Natural Health Products Guide, if alternate methods are used for testing to meet pharmacopoeial specifications, the relevant pharmacopoeia should be consulted for information on whether or not the alternate methods are considered suitable.
NHPID Name:
Creatine hydrochloride
Modification:
Removed Schedule 1: Isolate
NHPID Name:
Creatine hydrochloride
Additional Details removed:
The finished product and/or raw material specifications must have limits for the following impurities: not more than 100 ppm creatinine; not more than 50 ppm dicyandiamide; non-detectable dihydrotriazine. The method used to detect dihydrotriazine must have a limit of detection of not more than 5 ppm.
NHPID Name:
Polyethylene glycosylated creatine hydrochloride
Sub-ingredient(s) removed:
Creatine hydrochloride
NHPID Name:
Polyethylene glycosylated creatine hydrochloride
New Sub-ingredient(s) added:
Creatine
NHPID Name:
Polyethylene glycosylated creatine
New Sub-ingredient(s) added:
Creatine
NHPID Name:
Creatine monohydrate
Additional Details changed:
The finished product and/or raw material specifications must meet the process-related impurity acceptance criteria outlined in the USP Creatine monograph (or any other internationally recognized pharmacopoeia). Note that the NNHPD will accept these process-related impurity acceptance criteria for either the finished product or the raw material; however, the procedures described in the USP Creatine monograph are specific to the testing of creatine monohydrate raw material. As per the NNHPD Quality of Natural Health Products Guide, if alternate methods are used for testing to meet pharmacopoeial specifications, the relevant pharmacopoeia should be consulted for information on whether or not the alternate methods are considered suitable.
NHPID Name:
Benzophenone
Additional Details changed:
The presence of this ingredient as restricted on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in natural health products, unless additional evidence for safety is submitted.
NHPID Name:
Chlorocresol
New Additional Details added :
The presence of this ingredient as restricted on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in natural health products, unless additional evidence for safety is submitted.
NHPID Name:
D&C Violet No. 2
New Additional Details added :
The presence of this ingredient as restricted on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in natural health products, unless additional evidence for safety is submitted.
NHPID Name:
DEA-Cetyl phosphate
New Additional Details added :
The presence of this ingredient as prohibited on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient cannot be used in natural health products without the submission of additional evidence for safety.
NHPID Name:
DEA-Oleth-3 Phosphate
New Additional Details added :
The presence of this ingredient as prohibited on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient cannot be used in natural health products without the submission of additional evidence for safety.
NHPID Name:
Spermidine
New Additional Details added :
The presence of this ingredient as prohibited on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient cannot be used in natural health products without the submission of additional evidence for safety.
NHPID Name:
Diisopropylamine
New Additional Details added :
The presence of this ingredient as prohibited on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient cannot be used in natural health products without the submission of additional evidence for safety.
NHPID Name:
Potassium citrate
Additional Details changed:
The presence of this ingredient as restricted on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in natural health products, unless additional evidence for safety is submitted.
NHPID Name:
Potassium citrate, monohydrate
Additional Details changed:
The presence of this ingredient as restricted on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in natural health products, unless additional evidence for safety is submitted.
NHPID Name:
Sodium citrate
Additional Details changed:
In oral rehydration products, this ingredient is acceptable as a source of sodium. Sodium is an electrolyte, not a nutrient. As a medicinal ingredient, sodium does not contribute to the maintenance of good health since there is likely to be excess sodium from the diet, not a deficiency. The safety and efficacy of sodium citrate as a source of sodium must be assessed under the recommended conditions of use. The presence of this ingredient as restricted on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in natural health products, unless additional evidence for safety is submitted.
NHPID Name:
Sodium citrate dihydrate
Modification:
Removed Schedule 1: Isolate
NHPID Name:
Tricreatine citrate
Modification:
Removed Schedule 1: Isolate
NHPID Name:
Sodium Glycolate
New Additional Details added :
The presence of this ingredient as restricted on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in natural health products, unless additional evidence for safety is submitted.
NHPID Name:
Sodium hydrogen DL-malate
Additional Details changed:
The presence of this ingredient as restricted on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in natural health products, unless additional evidence for safety is submitted
NHPID Name:
Zinc malate
Additional Details changed:
The presence of this ingredient as restricted on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in natural health products, unless additional evidence for safety is submitted
NHPID Name:
Gluconolactone
New Additional Details added :
The presence of this ingredient as restricted on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in natural health products, unless additional evidence for safety is submitted
NHPID Name:
Calcium lactobionate, dihydrate
New Additional Details added :
The presence of this ingredient as restricted on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in natural health products, unless additional evidence for safety is submitted
NHPID Name:
Hydroquinone
Additional Details changed:
The presence of this ingredient as restricted on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in natural health products, unless additional evidence for safety is submitted
NHPID Name:
Talc
Additional Details changed:
The presence of this ingredient as restricted on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in natural health products, unless additional evidence for safety is submitted
NHPID Name:
Talc
New Toxicity restriction added:
Not permitted in products intended solely for use in the genital area of those who have ovaries. The risk statement "Do not use in the genital area of those who have ovaries" is required for products that could come in contact with the genital area (for example, diapering products, body powder, bath products). The concentration of talc should not exceed 51% in products in loose powder form that may be used for diapering and 77% in other products in loose powder form intended for use on the face or body; and in addition to other products in loose powder form (for example, dry shampoo, foot powder), the following risk statements are required: "Keep out of reach of children" and "Keep powder away from child's face to avoid inhalation, which can cause breathing problems".
NHPID Name:
Talcum
Additional Details changed:
This medicinal ingredient is specifically for use in traditional Chinese medicine products, and its preparation must comply with the method(s) described in the most current edition of the Pharmacopoeia of the People's Republic of China. The presence of this ingredient as restricted on the List of Prohibited and Restricted Cosmetic Ingredients (the Cosmetic Ingredient Hotlist) indicates that there are potential safety issues. This ingredient must be used in accordance with the restrictions set out on the Hotlist when included in natural health products, unless additional evidence for safety is submitted.
NHPID Name:
Protein
New Source Material(s) added:
Lemna minor (Parts: Whole plant); Lens culinaris (Parts: Seed); Linum usitatissimum (Parts: Seed); Medicago sativa (Parts: Herb top); Plukenetia volubilis (Parts: Seed); Salvia hispanica (Parts: Seed); Wolffia globosa (Parts: Whole plant)
NHPID Name:
Lemna minor
New Sub-ingredient(s) added:
Protein
NHPID Name:
Lens culinaris
New Sub-ingredient(s) added:
Protein
NHPID Name:
Linum usitatissimum
New Sub-ingredient(s) added:
Protein
NHPID Name:
Medicago sativa
New Sub-ingredient(s) added:
Protein
NHPID Name:
Plukenetia volubilis
New Sub-ingredient(s) added:
Protein
NHPID Name:
Salvia hispanica
New Sub-ingredient(s) added:
Protein
NHPID Name:
Wolffia Globosa
New Sub-ingredient(s) added:
Protein
NHPID Name:
Citrus Nobilis (Mandarin Orange) Peel Oil
Modification:
Removed Schedule 1: Extract
NHPID Name:
Citrus Nobilis (Mandarin Orange) Peel Oil
Method(s) of Preparation removed:
Oil, Essential (expression) Standardized
NHPID Name:
Magnesium
New Source Ingredient(s) added:
Magnesium Citrate Glycinate
NHPID Name:
Glycine
New Source Ingredient(s) added:
Magnesium Citrate Glycinate
NHPID Name:
Hydrolyzed Beef Protein
Modification:
Revised Category: Approved Chemical Name
NHPID Name:
Hydrolyzed Beef Protein
New Source Material(s) added:
Bos taurus (Parts: Bones and Meat)
NHPID Name:
Bos taurus
New Source Material(s) added:
New Source material Constituent(s): Bones and Meat
NHPID Name:
Bos taurus
Method(s) of Preparation removed:
Live
NHPID Name:
Bos taurus
New Method(s) of Preparation added:
Dry; Fresh
NHPID Name:
Sus scrofa
Method(s) of Preparation removed:
Live
NHPID Name:
Sus scrofa
New Method(s) of Preparation added:
Dry; Fresh
NHPID Name:
Hexamidine diisethionate
Removed NMI purpose(s):
Skin-Conditioning Agent - Emollient
NHPID Name:
Hydroxyethoxyphenyl Butanone
New NMI Purpose(s):
Preservative Antimicrobial
NHPID Name:
D-Psicose
Modification:
New Schedule 1: Isolate
NHPID Name:
Nicotine
New Source Ingredient(s) added:
Nicotine Malate
Monograph Modifications
In this update, the following single ingredient or product monographs were added or modified.
No Changes.
AbLS Modifications
In this update, the following abbreviated labelling standards were added or modified.
No Changes.
Controlled Vocabulary Modifications
In this update, the following controlled vocabulary (dosage forms, methods of preparation, quality test methods, etc) were added or modified.
No Changes.
Homeopathic Ingredient Modifications
In this update, the following homeopathic ingredients were added or modified.
NHPID Name:
HPUS_Antimonium tartaricum
Modification:
HPUS Class B Changed Minimum Homeopathic Potency: 6X
NHPID Name:
HPUS_Antimonium tartaricum
Modification:
HPUS Class F Changed Minimum Homeopathic Potency: 6X
RemIng
PREVIOUS WHAT'S NEW
- Whats New on May 31, 2024
- Whats New on April 26, 2024
- Whats New on March 28, 2024
- Whats New on February 23, 2024
- Whats New on January 26, 2024
- Whats New on December 29, 2023
- Whats New on November 24, 2023
- Whats New on October 27, 2023
- Whats New on September 29, 2023
- Whats New on August 25, 2023
- Whats New on July 28, 2023
- Whats New on June 30, 2023
- Whats New on May 26, 2023
- Whats New on April 28, 2023
- Whats New on March 31, 2023
- Whats New on February 24, 2023
- Whats New on January 27, 2023
- Whats New 2022
- Whats New 2021
- Whats New 2020
- Whats New 2019
- Whats New 2018
- Whats New 2017
- Whats New 2016
- Whats New 2015
- Whats New 2014
- Whats New July - December 2013
- Whats New January - June 2013
- Whats New July - December 2012
- Whats New January - June 2012
- Whats New July - December 2011
- Whats New January - June 2011
- Whats New for 2010